WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017186121) METHOD FOR IMPROVING FUNCTION OF IMMUNE RESPONSE CELL
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/186121    International Application No.:    PCT/CN2017/082024
Publication Date: 02.11.2017 International Filing Date: 26.04.2017
IPC:
C12N 15/09 (2006.01), C12N 5/10 (2006.01), A61K 35/17 (2015.01), A61P 35/00 (2006.01), A61P 37/02 (2006.01)
Applicants: CARSGEN THERAPEUTICS CO., LTD. [CN/CN]; Building B, Yindu Road 388 Shanghai 200231 (CN).
SHANGHAI CANCER INSTITUTE [CN/CN]; No.25, Lane 2200, Xietu Road Shanghai 200032 (CN)
Inventors: LI, Zonghai; (CN).
DI, Shengmeng; (CN).
GAO, Huiping; (CN).
WANG, Huamao; (CN)
Agent: AFD CHINA INTELLECTUAL PROPERTY LAW OFFICE; Suite B 1601A, 8 Xue Qing Rd., Haidian Beijing 100192 (CN)
Priority Data:
201610265614.1 26.04.2016 CN
201610536449.9 08.07.2016 CN
201611148447.9 13.12.2016 CN
Title (EN) METHOD FOR IMPROVING FUNCTION OF IMMUNE RESPONSE CELL
(FR) PROCÉDÉ D’AMÉLIORATION DE LA FONCTION D’UNE CELLULE DE RÉPONSE IMMUNITAIRE
(ZH) 一种改善免疫应答细胞功能的方法
Abstract: front page image
(EN)Provided are a method for improving the function of an immune response cell and an immune response cell which expresses at least one receptor capable of binding to an antigen and type I interferon. The cell has a significant ability to kill tumours or pathogens and can be used for treating tumours and infectious diseases.
(FR)La présente invention concerne un procédé d’amélioration de la fonction d’une cellule de réponse immunitaire et une cellule de réponse immunitaire qui exprime au moins un récepteur susceptible de liaison avec un antigène et un interféron de type I. La cellule présente une capacité considérable de tuer les tumeurs ou les pathogènes et peut être utilisée pour traiter les tumeurs et les maladies infectieuses.
(ZH)提供了一种改善免疫应答细胞功能的方法以及一种免疫应答细胞,该细胞表达至少一种能结合抗原的受体以及I型干扰素,具有显著的杀伤肿瘤或病原体的能力,可被用于治疗肿瘤和传染病。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: Chinese (ZH)
Filing Language: Chinese (ZH)